Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women

Completed · Phase 2

Conditions studied: Pregnancy

In brief

To determine the percentage of women who achieve anemia correction after a single dose of 1000mg of low molecular weight iron dextran(infed).

Key facts

Study ID

NCT02038023

Run by

Auerbach Hematology Oncology Associates P C

People needed

74

Starts

2013-07-01

Expected to finish

2015-08-01

Last updated by the study team

2018-06-28

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• pregnant women intolerable to oral iron. hbg <10.9 g/dl during second or third trimester.

You may not qualify if…

• known sensitivity to IV iron. hemoglobinopathies. hemolytic anemia. women who have received or will receive blood transfusions. women with significant vaginal bleeding(>200 cc blood loss)prior to delivery. women with documented history of allergy to more than one class of drug clinically significant anemia requiring therapy in the opinion of the obstetrician, in the first trimester.

Where it is running

• Auerbach Hematology Oncology Assoc — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.